This report provides comprehensive information on the current therapeutic developmental pipeline of Salix Pharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/salix-pharmaceuticals-ltd-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014
Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014
Summary
Global Markets Directs, Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014, provides an overview of the Salix Pharmaceuticals Ltd.s pharmaceutical
research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Salix Pharmaceuticals Ltd.s, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Salix Pharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Salix Pharmaceuticals Ltd.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Salix Pharmaceuticals Ltd.s pipeline products
Reasons to buy
- Evaluate Salix Pharmaceuticals Ltd.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Salix Pharmaceuticals Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Salix Pharmaceuticals Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in
those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Salix Pharmaceuticals Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Salix Pharmaceuticals Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Salix Pharmaceuticals Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
salix Pharmaceuticals Ltd. Snapshot 5
salix Pharmaceuticals Ltd. Overview 5
key Information 5
key Facts 5
salix Pharmaceuticals Ltd. - Research And Development Overview 6
key Therapeutic Areas 6
salix Pharmaceuticals Ltd. - Pipeline Review 8
pipeline Products By Stage Of Development 8
pipeline Products - Monotherapy 9
pipeline Products - Partnered Products 10
partnered Products/combination Treatment Modalities 11
Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014

2. salix Pharmaceuticals Ltd. - Pipeline Products Glance 12
salix Pharmaceuticals Ltd. - Late Stage Pipeline Products 12
pre-registration Products/combination Treatment Modalities 12
phase Iii Products/combination Treatment Modalities 13
salix Pharmaceuticals Ltd. - Clinical Stage Pipeline Products 14
phase Ii Products/combination Treatment Modalities 14
salix Pharmaceuticals Ltd. - Drug Profiles 15
budesonide 15
product Description 15
mechanism Of Action 15
r&d Progress 15
methylnaltrexone Bromide 18
product Description 18
mechanism Of Action 18
r&d Progress 18
rifaximin 21
product Description 21
mechanism Of Action 21
r&d Progress 21
budesonide Er 23
product Description 23
mechanism Of Action 23
r&d Progress 23
rhb-106 25
product Description 25
mechanism Of Action 25
r&d Progress 25
san-300 26
product Description 26
mechanism Of Action 26
r&d Progress 26
salix Pharmaceuticals Ltd. - Pipeline Analysis 27
salix Pharmaceuticals Ltd. - Pipeline Products By Target 27
salix Pharmaceuticals Ltd. - Pipeline Products By Route Of Administration 28
salix Pharmaceuticals Ltd. - Pipeline Products By Molecule Type 29
salix Pharmaceuticals Ltd. - Pipeline Products By Mechanism Of Action 30
salix Pharmaceuticals Ltd. - Recent Pipeline Updates 31
salix Pharmaceuticals Ltd. - Dormant Projects 39
salix Pharmaceuticals Ltd. - Company Statement 40
salix Pharmaceuticals Ltd. - Locations And Subsidiaries 42
head Office 42
other Locations & Subsidiaries 42
appendix 44
methodology 44
coverage 44
secondary Research 44
primary Research 44
expert Panel Validation 44
contact Us 45
disclaimer 45
list Of Tables
salix Pharmaceuticals Ltd., Key Information 5
salix Pharmaceuticals Ltd., Key Facts 5
salix Pharmaceuticals Ltd. - Pipeline By Indication, 2014 7
salix Pharmaceuticals Ltd. - Pipeline By Stage Of Development, 2014 8
salix Pharmaceuticals Ltd. - Monotherapy Products In Pipeline, 2014 9
salix Pharmaceuticals Ltd. - Partnered Products In Pipeline, 2014 10
salix Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
salix Pharmaceuticals Ltd. - Pre-registration, 2014 12
salix Pharmaceuticals Ltd. - Phase Iii, 2014 13
salix Pharmaceuticals Ltd. - Phase Ii, 2014 14
salix Pharmaceuticals Ltd. - Pipeline By Target, 2014 27
salix Pharmaceuticals Ltd. - Pipeline By Route Of Administration, 2014 28
salix Pharmaceuticals Ltd. - Pipeline By Molecule Type, 2014 29
salix Pharmaceuticals Ltd. - Pipeline Products By Mechanism Of Action, 2014 30
salix Pharmaceuticals Ltd. - Recent Pipeline Updates, 2014 31
salix Pharmaceuticals Ltd. - Dormant Developmental Projects,2014 39
Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014

3. salix Pharmaceuticals Ltd., Subsidiaries 42
list Of Figures
salix Pharmaceuticals Ltd. - Pipeline By Top 10 Indication, 2014 7
salix Pharmaceuticals Ltd. - Pipeline By Stage Of Development, 2014 8
salix Pharmaceuticals Ltd. - Monotherapy Products In Pipeline, 2014 9
salix Pharmaceuticals Ltd. - Partnered Products In Pipeline, 2014 10
salix Pharmaceuticals Ltd. - Pipeline By Top 10 Target, 2014 27
salix Pharmaceuticals Ltd. - Pipeline By Top 10 Route Of Administration, 2014 28
salix Pharmaceuticals Ltd. - Pipeline By Top 10 Molecule Type, 2014 29
salix Pharmaceuticals Ltd. - Pipeline Products By Top 10 Mechanism Of Action, 2014 30
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Salix Pharmaceuticals Ltd. - Product Pipeline Review - 2014